E676-1054 Screening compound: N-[2-(dimethylamino)ethyl]-N-(4-methoxy-1,3-benzothiazol-2-yl)-1,3-benzothiazole-2-carboxamide

E676-1054 Screening compound: N-[2-(dimethylamino)ethyl]-N-(4-methoxy-1,3-benzothiazol-2-yl)-1,3-benzothiazole-2-carboxamide
E676-1054 Screening compound: N-[2-(dimethylamino)ethyl]-N-(4-methoxy-1,3-benzothiazol-2-yl)-1,3-benzothiazole-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E676-1054
N-[2-(dimethylamino)ethyl]-N-(4-methoxy-1,3-benzothiazol-2-yl)-1,3-benzothiazole-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E676-1054

Molecular Formula

C20H20N4O2S2 (C20 H20 N4 O2 S2)

Compound Name

N-[2-(dimethylamino)ethyl]-N-(4-methoxy-1,3-benzothiazol-2-yl)-1,3-benzothiazole-2-carboxamide

IUPAC name

N-[2-(dimethylamino)ethyl]-N-(4-methoxy-13-benzothiazol-2-yl)-13-benzothiazole-2-carboxamide

SMILES

CN(C)CCN(C(c1nc(cccc2)c2s1)=O)c1nc(c(OC)ccc2)c2s1

InChI

InChI=1S/C20H20N4O2S2/c1-23(2)11-12-24(19(25)18-21-13-7-4-5-9-15(13)27-18)20-22-17-14(26-3)8-6-10-16(17)28-20/h4-10H,11-12H2,1-3H3

InChI Key

OKJAJYXIRLFIKW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD11984842

Chemical and Physical Properties

Saltdata

HCl

Molecular Weight

412.54

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.407

Distribution Coefficient, logD

3.764

Water Solubility, LogSw

-4.44

Polar Surface Area

47.362

Acid Dissociation Constant (pKa)

24.17

Base Dissociation Constant (pKb)

7.93

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

25.00

E676-1054 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Angiogenesis library (14822 compounds)

Antiviral Library (67538 compounds)

CNS Targets (44014 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Antiviral
  • Infections
  • Immune system
  • Nervous system
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with E676-1054 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E676-1054?
Check Price and Availability of E676-1054, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E676-1054 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E676-1054
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E676-1054
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E676-1054 available by request